
CAS Number20897-91-0
Synonyms3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid; 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid; (13E)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid; (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid; 9-oxo-11alpha,15r-dihydroxy-prost-13e-en-1-oic acid; 15-epi pge1; (11α,13E,15R)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
Molecular FormulaC20H34O5
Molecular Weight352.47
Purity98.00%
Density1.1±0.1 g/cm3
Boiling Point529.3±50.0 °C at 760 mmHg
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 20897-91-0 |
| Catalog No. | 2A-1192796 |
| Chinese Name | (13E)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid |
| Synonyms | 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid; 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid; (13E)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid; (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid; 9-oxo-11alpha,15r-dihydroxy-prost-13e-en-1-oic acid; 15-epi pge1; (11α,13E,15R)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid; l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid |
| Molecular Formula | C20H34O5 |
| Molecular Weight | 352.47 |
| Purity | 98.00 |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 529.3±50.0 °C at 760 mmHg |
| Storage Condition | -20°C, sealed, dry |
| MDL Number | MFCD00011310 |
| SMILES | CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O |
| InChI Key | GMVPRGQOIOIIMI-CHCORRSHSA-N |
| NACRES Code | NA.25 |
| UNSPSC | 12352211 |
| Transport Info | Product Name: 15(R)-Prostaglandin E1 |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| 4-Phenyl-1H-pyrrolo[2,3-b]pyridine-6-carboxylic acid | 1261753-39-2 | 2A-1192651 |
| (1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-METHANOL | 849067-97-6 | 2A-1192660 |
| (R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium | 2480467-84-1 | 2A-1192763 |
| 4-[(4-Morpholinylthio)thioxomethyl]-morpholine | 13752-51-7 | 2A-1192773 |
| 4-FLUORO-3-NITROBENZENESULFONYL CHLORIDE | 6668-56-0 | 2A-1192786 |
| (R)-3-(diMethylaMino)-1-(thiophen-2-yl)propan-1-ol | 132335-49-0 | 2A-1192797 |
| (S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine | 116817-27-7 | 2A-1192811 |
| 2-Pyridinecarboxamide, N-[(1S,2S)-2-(dimethylamino)cyclohexyl]-5-phenyl- | 2798827-15-1 | 2A-1192834 |
| 3-(2,4-Dichloro-5-methoxyphenyl)-2,3-dihydro-2-thioxo-4(1H)-quinazolinone | 338967-87-6 | 2A-1192845 |
| 2-hydroxy-3-trifluoromethanesulfonyloxy-benzoate | 351002-09-0 | 2A-1192847 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA